Pain control strategy reduces need for opioids in patients with head and neck cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Gabapentin is an effective alternative to standard pain-control drugs and can manage head and neck cancer pain and symptoms without the need for narcotics, a study published in Cancer found.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.

Login